These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9731718)
21. Aryl hydrocarbon hydroxylase in persons with lung or laryngeal cancer. Ward E; Paigen B; Steenland K; Vincent R; Minowada J; Gurtoo HL; Sartori P; Havens MB Int J Cancer; 1978 Oct; 22(4):384-9. PubMed ID: 212378 [TBL] [Abstract][Full Text] [Related]
22. Population distribution of placental benzo(a)pyrene metabolism in smokers. Gurtoo HL; Williams CJ; Gottlieb K; Mulhern AI; Caballes L; Vaught JB; Marinello AJ; Bansal SK Int J Cancer; 1983 Jan; 31(1):29-37. PubMed ID: 6299972 [TBL] [Abstract][Full Text] [Related]
23. Role of the 4-5S binding protein in the induction of aryl hydrocarbon hydroxylase in the rat. Harris M; Kamps C; Safe S Carcinogenesis; 1988 Aug; 9(8):1475-9. PubMed ID: 3402044 [TBL] [Abstract][Full Text] [Related]
24. The relationship between aryl hydrocarbon hydroxylase activity and DNA adducts measured by (32)P-postlabelling assay in lymphocytes of lung cancer patients. Zhang J; Ichiba M; Kiyohara C; Nakanishi Y; Takayama K; Hara N; Tomokuni K Biomarkers; 2000; 5(2):152-7. PubMed ID: 23885952 [TBL] [Abstract][Full Text] [Related]
25. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms. Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499 [TBL] [Abstract][Full Text] [Related]
26. Suppression of aryl hydrocarbon hydroxylase activity in human primary lung carcinoma x mouse hepatoma somatic cell hybrids. Manjunath GS; Dufresne MJ Biochem Int; 1989 Aug; 19(2):413-20. PubMed ID: 2818604 [TBL] [Abstract][Full Text] [Related]
27. Correlation of inducibility of aryl hydrocarbon hydroxylase with susceptibility to 3-methylcholanthrene-induced lung cancers. Kouri RE; Billups LH; Rude TH; Whitmire CE; Sass B; Henry CJ Cancer Lett; 1980 Jun; 9(4):277-84. PubMed ID: 7397681 [TBL] [Abstract][Full Text] [Related]
28. [Applications of aryl hydrocarbon hydroxylase in diagnosis of lung cancer]. Chen L; Liu Y Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):151-4. PubMed ID: 11778487 [TBL] [Abstract][Full Text] [Related]
29. Acquisition of aryl hydrocarbon hydroxylase inducibility by aromatic hydrocarbons in monolayer-cultured hepatocytes from nonresponsive mouse strains. Nemoto N; Sakurai J; Tazawa A; Ishikawa T Cancer Res; 1990 Jun; 50(11):3226-30. PubMed ID: 1692256 [TBL] [Abstract][Full Text] [Related]
30. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Nakajima T; Elovaara E; Anttila S; Hirvonen A; Camus AM; Hayes JD; Ketterer B; Vainio H Carcinogenesis; 1995 Apr; 16(4):707-11. PubMed ID: 7728947 [TBL] [Abstract][Full Text] [Related]
31. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms. Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750 [TBL] [Abstract][Full Text] [Related]
32. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm. Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816 [TBL] [Abstract][Full Text] [Related]
33. CYP1A1 Ile462Val polymorphism and the risk of non-small cell lung cancer in a Chinese population. Lin J; He B; Cao L; Zhang Z; Liu H; Rao J; Liu Y; Shao S; Wang G; Zhang X Tumori; 2014; 100(5):547-52. PubMed ID: 25343551 [TBL] [Abstract][Full Text] [Related]
34. Effects of cigarette smoking on aryl hydrocarbon hydroxylase activity in lungs and tissues of inbred mice. Abramson RK; Hutton JJ Cancer Res; 1975 Jan; 35(1):23-9. PubMed ID: 1109792 [TBL] [Abstract][Full Text] [Related]
35. Aryl hydrocarbon hydroxylase inducibility is not altered in bladder cancer patients or their progeny. Paigen B; Ward E; Steenland K; Havens M; Sartori P Int J Cancer; 1979 Mar; 23(3):312-5. PubMed ID: 437914 [TBL] [Abstract][Full Text] [Related]
36. Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case--control multicenter study on lung cancer patients. Bartsch H; Petruzzelli S; De Flora S; Hietanen E; Camus AM; Castegnaro M; Alexandrov K; Rojas M; Saracci R; Giuntini C Environ Health Perspect; 1992 Nov; 98():119-24. PubMed ID: 1336722 [TBL] [Abstract][Full Text] [Related]
37. Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer. Anttila S; Hirvonen A; Husgafvel-Pursiainen K; Karjalainen A; Nurminen T; Vainio H Carcinogenesis; 1994 Jun; 15(6):1133-5. PubMed ID: 8020145 [TBL] [Abstract][Full Text] [Related]
38. [Mechanism of the mutagenic/carcinogenic action of cigarette smoke at the pulmonary level: enzymatic induction, activation and detoxification]. Scassellati Sforzolini G; Pasquini R; Savino A; Monarca S Ann Ig; 1989; 1(1-2):295-311. PubMed ID: 2483074 [TBL] [Abstract][Full Text] [Related]
39. CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Anttila S; Tuominen P; Hirvonen A; Nurminen M; Karjalainen A; Hankinson O; Elovaara E Pharmacogenetics; 2001 Aug; 11(6):501-9. PubMed ID: 11505220 [TBL] [Abstract][Full Text] [Related]
40. Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Oyama T; Mitsudomi T; Kawamoto T; Ogami A; Osaki T; Kodama Y; Yasumoto K Int Arch Occup Environ Health; 1995; 67(4):253-6. PubMed ID: 7591186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]